Background: Catechol-O-methyltransferase (COMT) is an important estrogen-metabolizing enzyme. Numerous case-control studies have evaluated the role COMT Val 158Met (rs4680;472G->A) polymorphism in the risk of breast cancer and provided inconclusive results, hence present meta-analysis was designed to get a more reliable assessment in Asian population. Methods: A total of 26 articles were identified through a search of four electronic databases-PubMed, Google Scholar, Science Direct and Springer link, up to March, 2016. Pooled odds ratios (ORs) with 95% con¬fidence intervals (CIs) were used as association measure to find out relationship between COMT Val158Metpolymorphism and the risk of breast cancer. We also assessed between study heterogeneity and publication bias. All statistical analyses were done by Open Meta-Analyst. Results: Twenty six case-control studies involving 5,971 breast cancer patients and 7,253 controls were included in the present meta-analysis. The results showed that the COMT Val158Met polymorphism was significantly associated with breast cancer risk except heterozygote model(allele contrast odds ratio (ORAvsG)= 1.13, 95%CI=1.02-1.24,p=0.01; heterozygote/co-dominant ORGAvsGG= 1.03, 95%CI=0.96-1.11,p=0.34; homozygote ORAAvsGG= 1.38, 95%CI= 1.08-1.76,p=0.009; dominant model ORAA+GAvsGG= 1.08, 95%CI=1.01-1.16,p=0.02; and recessive model ORAAvsGA+GG= 1.35, 95%CI=1.07-1.71,p=0.01). In addition, we also performed subgroup analysis based on source of controls and menopausal state of patients. Conclusions: In conclusion, the COMT Val158Met polymorphism was related to increased breast cancer susceptibility in the Asian population.
Introduction
Breast cancer (BC)is the leading cause of cancer death among females (Jemal et al., 2011; Guo et al., 2012) and its development is a multifactorial complex process influenced by multiple genetic variants and environmental factors (Nathanson et al.,2001; Guo et al., 2012) . Estrogen hormones affect the cell growth and proliferation during breast carcinogenesis and metabolized by several enzyme including COMT, which metabolized itinto biologically non-hazardous methoxyestrogens (Onay et al., 2008) . COMT enzyme are found in two isoforms in the cells: a cytoplasmic smaller protein (S-COMT; 221 aa) and a membrane-bound longer protein (MB-COMT 271 aa) (Tenhunen et al. 1994) .
COMT gene is present at chromosome 22q11.1 and a single base pair G-->A substitution at position 472(G472A/Val158Met)in exon 4, results in substitution of valine by methionine in COMT enzyme (Lotta et al., 1995; Lachman et al., 1996) . The two alleles are referred to as Val(G) and Met(A). Val allele encodes the thermostable high activity COMT enzyme and Met allele encodes the RESEARCH ARTICLE
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Vandana Rai*, Upendra Yadav, Pradeep Kumar thermolabile low activity COMT enzyme (Spielman and Weinshilboum, 1981; Lotta et al., 1995; Nobile et al., 2010) . Both the alleles are co-dominant, i.e. heterozygous individuals (Val/Met) have an intermediate level of COMT activity (Lotta et al., 1995) .The frequency of the mutant Met allele vary greatly among the populations studied, frequency of Met allele is reported as 0.56 in American (Vandenbergh et al., 1997) , 0.5 in European (Kunugi et al., 1997) , and 0.27 in Asian (Chen et al., 1997) populations. COMT gene Val158Met is a clinically functional polymorphism, and reported as risk factor for several disorders/diseases-schizophrenia (Kayahan et al., 2013) , attention-deficit hyperactivity disorder (Retz et al., 2008) , autism (Gadow et al., 2009) ,drug abuse (Vinkers et al., 2013) , posttraumatic stress disorder (Valente et al., 2011) , and cancer (Omrani et al., 2009) 
COMT enzyme metabolized estrogen and its carcinogenic derivatives, hence study of COMT gene polymorphisms as risk for cancer is of particular interest. In the past years, several case-control studies have been investigated the association between COMT Val158Met polymorphisms and breast cancer susceptibility (Kocabas et al.,2002; Wen et al., 2005; Chang et al.,2006; Wang et al., 2010; Naushad et al., 2011; Lajin et al.,2013) . However, individual study limitations contributed to divergent conclusions among them. Aim of the present meta-analysis was to find out the relationship between COMT Val158Met polymorphism and breast cancer risk in Asian population.
Materials and Methods

Data Sources, Search Strategy, and Selection Criteria
The articles for the present meta-analysis were retrieved by searching the PubMed (http://www.ncbi. nlm.nih.gov/pubmed), Google Scholar (http://scholar. google.com), Science Direct (http://www.sciencedirect. com), and Springer Link (http://link.springer.com) databases up to March, 2016, using the keywords "breast cancer", "Val158Met", "Catechol-O-methyltransferase" and "COMT".
Article selection for the present meta-analysis used the following inclusion criteria:(i) study should be casecontrol; (ii) sufficient genotype/allele data to calculate the odds ratios (ORs) with 95% confidence intervals should be reported (CIs).Exclusion criteria were the following: (i) only cases were analyzed; (ii) editorial, review articles etc.;(iii)not sufficient data/information to calculate odds ratio with 95%CI were reported; (v) other cancer type were investigated in the study and (vi) non-Asian breast cancer cases were investigated.
Data Extraction and Quality Assessment
Data extraction and quality assessment were performed by two investigators (PK and UY). From each included relevant article, the following data were extracted: the family name of first author, the publication year, journal name, country name, the study design i.e. source of controls, the sample size, and the genotype distribution for the participants. Method of Guo et al., (2012) was adopted for study quality assessment. The quality scores ranged from 0 to 10 and studies with score <5 was defined as low quality, and studies with score ≥7 was defined as high quality.
Statistical Analysis
Odds ratios (ORs) with corresponding 95% confidence intervals (CIs) were used as the measure of association between the COMT Val158Met polymorphism and breast cancer susceptibility. Data were pooled using the fixed effect (Mantel and Haenszel,1959) and random effect (DerSimonian and Laird, 1987) methods. p<0.05 was considered as statistically significant. Heterogeneity between conducted by X2-based Q-test and quantified by I2 (Cochran,1954; Higgins and Thompson, 2002; Whitehead, 2002 (Egger et al., 1997) . All statistical analyses were performed by Open Meta-Analyst (Wallace et al., 2013) .
Results
Literature Search
Initial search of four databases, 203 articles were retrieved, but 141 articles did not meet the inclusion criteria after reviewing abstract. The excluded articles include results of drug treatments of breast cancer, book chapter, comments, editorials, reviews, meta-analysis and articles investigated other genes. Out of remaining sixty two articles, we also excluded thirty nine articles, in which investigated subjects were not from Asian population. After applying inclusion/exclusion criteria, total 23articles ( Figure 1) were suitable for the present meta-analysis (Huang et al., 1999; Hamajima et al., 2001; Yim et al., 2001; Kocabas et al., 2002; Tan et al., 2003; Wu et al., 2003; Sazci et al., 2004; Cheng et al., 2005; Lin SC et al., 2005; Lin WY et al., 2005; Wen et al., 2005; Chang et al., 2006; Akisik and Dalay, 2007; Fan et al., 2007; Hu et al., 2007; Sangrajrang et al., 2009; Yadav et al., 2009; Syamala et al., 2010; Xu et al., 2010; Naushad et al., 2011; Wang et al., 2011; Lajin et al., 2013; Li et al., 2013) .These studies were published between 1999 to 2013. One author (Syamala et al.,2010 ) studied sporadic and familial cases both and reported separately in their article, so we also included both groups of data as separate studies. Japanese and Filipino) so we included them as three separate studies. Hence total twenty six studies were included in the present meta-analysis. Characteristics of all the included studies were given in Table 1 . These studies were carried out in different countries-China (Huang et al., 1999; Tan et al.,2003; Wu et al., 2003; Cheng et al., 2005; Lin WY et al.,2005; Wen et al., 2005; Chang et al., 2006; Fan et al., 2007; Hu et al., 2007; Xu et al., 2010; Wang et al., 2011; Li et al., 2013) , India (Yadav et al., 2009; Syamala et al., 2010; Naushad et al., 2011) , Japan (Hamajima et al., 2001; Yim et al., 2001; Wu et al., 2003) , Philippines (Wu et al., 2003) , Syria (Lajin et al., 2013) , Taiwan (Lin SC et al., 2005) ,Thailand (Sangrajrang et al., 2009) , Turkey (Kocabas et al., 2002; Sazci et al., 2004; Akisik and Dalay, 2007) .
Study Characteristics
All twenty six studies were published between 1999 (Huang et al., 1999) to 2013 . Smallest sample size of cases studied was 59 (Yadav et al., 2009) and largest sample size was 1,120 (Wen et al., 2005) . In twelve studies, age and sex matched controls are selected from hospital and in eleven studies controls were selected from population. In three studies source of controls were not given. Control population of two studies (Yim et al., 2001; Sazciet al., 2004) were not in HWE. In eleven studies, selected patients were of premenopausal state and in ten studies cases were at postmenopausal state.
In remaining studies menopausal status of patients was not given. Total cases were 5,971 with GG (2,844), GA (2,432) and AA (695) genotypes and controls were 7,253 with GG (3,584), GA (2,998) and AA (671) genotypes. In total cases, genotypes percentage of GG, GA and AA were 47.63%, 40.73% and 11.64% respectively. In controls, genotypes percentage of GG, GA and AA were 49.41, 41.34% and 9.25%respectively.Out of twenty six studies, six studies did not report any association between COMT Val158Met and breast cancer (Lin SC et al., 2005; Lin WY et al., 2005; Wen et al., 2005; Chang et al., 2006; Yadav et al., 2009; Lajin et al., 2013) .
Meta-analysis
Meta-analysis with allele contrast (A vs. G) showed significant association with both fixed effect (ORAvsG= 1.10; 95%CI= 1.05-1.17; p= <0.001) and random effect model (ORAvsG= 1.13; 95% CI= 1.02-1.24; p= 0.01) (Table 2, Figure 2 ). There was observed an increased risk of breast cancer using homozygote model (AA vs GG; homozygote model), with both fixed (ORAAvsGG= 1.32; 95%CI= 1.17-1.49; p= <0.001) and random (ORAAvsGG= 1.38; 95%CI= 1.08-1.76; p=0.009) effect models with high statistical heterogeneity between studies (Table 2, Figure 3 ). Association of . Funnel Plots a-f, a. Precision by log odds ratio for additive model; b, standard error by log odds ratio for additive model; c, precision by log odds ratio for homozygote model; d, standard error by log odds ratio for homozygote model; e, precision by log odds ratio for recessive model; f, standard error by log odds ratio for recessive model. Figure 4) .
Subgroup analysis
Subgroup analysis were done on the basis of source of control (i.e. hospital based or population based) and status of menopause (i.e. premenopause and postmenopause).In total 26 studies, in 12 studies controls were selected from hospital and in remaining studies control samples were selected from population. In allele contrast meta-analysis with twelve studied of hospital based, showed significant association between COMT Val158Met polymorphism and breast cancer (ORAvsG = 1.18; 95%CI= 1.01-1.36; p= 0.02; I2=65.2%) and meta-analysis of eleven population based studies did not show any association(ORAvsG = 1.02; 95%CI= 0.94-1.10; p= 0.59; I 2 =48.22%).In three studies details of control samples were not given.
In eleven studies, subject were of premenopausal state, allele contrast meta-analysis showed meager association between COMT Val158Met polymorphism and breast cancer (ORAvsG= 1.11; 95%CI= 1.00-1.23; p= 0.03; I 2 = 38.27%), but meta-analysis of ten studies analysed postmenopausal subject did not show any association (ORAvsG= 1.04; 95%CI= 0.92-1.18; p= 0.46; I 2 = 20.18%). In four studies menopausal state of subjects were not mentioned.
Sensitivity analysis
In allele contrast meta-analysis, sensitivity analysis performed by exclusion of studies in which control population was not in HWE. Exclusion of two studies not in HWE (Yim et al., 2001; Sazciet al., 2004) did not affect heterogeneity but increased odds ratio (OR= 1.12; 95%CI= 1.01-1.23; p= 0.02).
Publication bias
Publication bias was absent in all five genetic models and P value of Egger's test was greater than 0.05 (A vs G, p= 0.36; AG vs GG, p= 0.87; AA vs GG, p= 0.33; AA+AG vs GG, p= 0.61; AA vs AG+GG, p= 0.27). Funnel plots using standard error and precision were also symmetrical ( Figure 5 ).
Discussion
Present meta-analysis of the association of the COMT Val158Met polymorphism with BC investigated 5,971 BC patients and 7,253 controls from 26 Asian case-control studies. The overall meta-analysis detected significant genetic association between the COMT Val158Met polymorphism and BC in Asian population. Five metaanalysis studies have been published so far on COMT Val 158Met polymorphism and breast cancer risk (Ding et al.,2010; He et al., 2012; Qin et al., 2012; Li et al., 2014; Wan et al., 2014) and reported no significant association. In all these five meta-analyses, information of Asian population is incomplete, hence present metaanalysis was conducted on case-control reports on Asian population and results suggested that the COMT Val158Met polymorphism is a risk factor for breast cancer development in the Asian population.
The COMT enzyme catalyzes the transfer of a methyl group from the S-adenosyl-L-methionine to the m-hydroxy group of catechol compounds, rendering the catechol estrogens more water soluble and enhancing excretion from the body (Service,1998; Ahsan et al., 2004) . Several studies suggested protective role to COMT higher activity isoform, which protect reactive oxygen induced DNA damage, that are produced by estrogen oxidation (Onay et al., 2008) . Prolonged exposure to estrogen is a risk factor for breast carcinoma (Hoffman et al., 1979; Amin et al., 1983; Lajin et al., 2013) . Catechol estrogen metabolitesare genotoxic andcapable of initiating mammary tumors through their reactive metabolites by formation of depurinatingDNA adducts which are capable of creating de novo oncogenic mutations (Jan et al., 1998; Ahsan et al., 2004; Lajin et al., 2013) .
Meta-analysis is a powerful statistical tool for analyzing cumulative data of case-control studies wherein the individual sample sizes are small and potentially investigates a large number of individuals and can estimate the effect of a genetic factor on the risk of the disease (Liwei et al., 2009; Li et al., 2013; Rai et al., 2014; Kumar et al., 2015) .Several meta-analyses investigating the association of COMT Val158Met polymorphism with various disease/disorders have been published, like-attention-deficit/hyperactivity disorder (Sun et al., 2014) , schizophrenia (Munafo et al., 2005) , prostate cancer (Xiao et al., 2013; Zou et al., 2013) etc.
The present meta-analysis has few limitations like-(i) meta-analysis based on unadjusted data, (ii)there is marked heterogeneity among studies, and (iii)owing to the lack of information, gene-gene interactions were not done.
In conclusion, the results of present meta-analysis support significant association between the COMT Val158Met polymorphism and breast cancer risk in Asian population. The results should be interpreted cautiously due to presence of high heterogeneity. In future, case control studies from different ethnic populations with larger sample sizes should be carried out to confirm the association between COMT Val158Met polymorphism and breast cancer. Further, gene-gene and gene-environmental interactions should also be investigated.
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